Marshall Wace, LLP Alector, Inc. Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
A detailed history of Marshall Wace, LLP transactions in Alector, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 48,448 shares of ALEC stock, worth $62,497. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,448
Previous 54,000
10.28%
Holding current value
$62,497
Previous $252,000
63.89%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ALEC
# of Institutions
156Shares Held
55MCall Options Held
39.7KPut Options Held
51K-
Ra Capital Management, L.P. Boston, MA9.7MShares$12.5 Million0.3% of portfolio
-
Black Rock Inc. New York, NY9.1MShares$11.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.62MShares$7.25 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.91MShares$2.47 Million0.0% of portfolio
-
State Street Corp Boston, MA1.85MShares$2.39 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $107M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...